Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC)

Aberrant expression of the chemokine CXC receptor 4 (CXCR4) is closely associated with cancer progression and drug-resistance in multiple cancers, and we first investigated the role of CXCR4 in regulating cancer pathogenesis and cisplatin (DDP)-resistance in clear cell renal cell carcinoma (ccRCC) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenguang, Gan, Zhilu, Liu, Qiang, Yan, Shenshen, Mulati, Rexiti, Wang, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806489/
https://www.ncbi.nlm.nih.gov/pubmed/34180759
http://dx.doi.org/10.1080/21655979.2021.1943112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806489/
https://www.ncbi.nlm.nih.gov/pubmed/34180759
http://dx.doi.org/10.1080/21655979.2021.1943112

Ejemplares similares